Fibrocystic disease of the breast.
D000232:Adenofibroma / Q000473:pathology; D000293:Adolescent; D000328:Adult; D000726:Androgen Antagonists / Q000494:pharmacology; D000728:Androgens / Q000494:pharmacology; D000818:Animals; D001941:Breast Diseases / Q000473:pathology; D001943:Breast Neoplasms / Q000139:chemically induced; D003613:Danazol / Q000627:therapeutic use; D004285:Dogs; D004967:Estrogens / Q000009:adverse effects / Q000494:pharmacology; D005260:Female; D005348:Fibrocystic Breast Disease / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D006041:Goats; D006801:Humans; D008297:Male; D008875:Middle Aged; D011374:Progesterone / Q000009:adverse effects; D011388:Prolactin / Q000494:pharmacology; D051381:Rats
D000726:Androgen Antagonists; D000728:Androgens; D004967:Estrogens; D011374:Progesterone; D011388:Prolactin; D003613:Danazol